In this article TSN PLCE PYPL Follow your favorite stocksCREATE FREE ACCOUNT Tyson food meat products are shown in this photo illustration in Encinitas, California. Mike Blake | Reuters Check out the companies making headlines in premarket trading. Tyson Foods – Shares of the food processing giant suffered a 6% drop in premarket trading after
After a rough outing in 2022, many of the best growth stocks are trading at bargain valuations. In fact, some are offering what some would consider a once-in-a-lifetime opportunity. The S&P 500 currently sits at a price-earnings ratio just above 19 after peaking around 40. Furthermore, many companies are reporting better-than-expected profits and are increasing their bottom line through
The rise of AI stocks as a key investing trend is notable. Whether we’re talking about ChatGPT or other incredible applications of artificial intelligence technology, it’s clear there’s plenty of disruption on the horizon in this space. Of course, plenty of AI companies have popped up, aimed at different segments of the market. Some are focused on
In this episode, Preston and Stig discuss billionaire Howard Marks’ book, The Most Important Thing. The topics discussed include risk management, probability projections, credit cycle timing, and the efficient market hypothesis. You won’t want to miss this engaging discussion from a book written by one of the best investors in the world. IN THIS EPISODE,
Already on an upward trajectory ahead of earnings, SoFi Technologies (NASDAQ:SOFI) stock has kept soaring following the release of its latest results. Since hitting new lows in December, SOFI has bounced back by around 80%, from $4.24 to about $7.50 per share. But while the latest numbers paint a stronger picture of the new bank’s prospects,
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic value. They’re also following regulatory pathways to gain approval for such treatments, too. Better, studies have shown promising results with psilocybin and other hallucinogens for mental health issues such as
Will Microsoft (NASDAQ:MSFT) demonstrate powerful growth in 2023? Anything is possible, but there isn’t strong evidence that MSFT stock will be a big winner this year. Both the recent financial data and Microsoft’s outlook for the future suggest that the company could disappoint hope-fueled investors. The outlook is uncertain as Microsoft plans to cut 10,000 jobs, roughly
With the Nasdaq nearly in a bull market (believe it or not), many companies reporting solid earnings, and the stock market coming off a scorching hot January, I’m very optimistic about stocks. But just as “there’s always a bull market somewhere,” as CNBC’s Jim Cramer loves to say, there are always overvalued stocks to sell. Now is no exception.